Structure of ar lbd with activator peptide and sarm inhibitor 2

Discovery of diarylhydantoins as new selective androgen receptor modulators.

Dihydrotestosterone receptor, Nuclear receptor subfamily 3 group C member 4

PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMG
WRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDEL
RMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGK
VKPIYFHTQ

Hanging drop set up as a 50:50 mixture of 1 uL protein, 1 uL reservoir with: A) protein solution = 80 uL hAR LBD (3.5 mg/ml), 1.5 uL undecapeptide, 1 uL LiSO4 (0.2 M) in HEPES buffer 0.1 M, 0.5 mg inhibitor 2 (PK1) Reservoir 1 ml HEPES buffer 0.1 M, PEG 4000 12-20 %, pH 7.5, VAPOR DIFFUSION, temperature 291K

CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH DIHYDROTESTOSTERONE

CRYSTAL STRUCTURE OF AR LBD WITH SHP PEPTIDE NR BOX 2

DIARYLHYDANTOIN, SYNTHESIS, ANTIANDROGEN, ANDROGEN RECEPTOR, testosterone, Selective Androgen Receptor Modulator, Dihydrotestosterone, TRANSCRIPTION

BINDING SITE FOR CHAIN B OF ANDROGEN RECEPTOR